1. Home
  2. EDSA vs AMIX Comparison

EDSA vs AMIX Comparison

Compare EDSA & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • AMIX
  • Stock Information
  • Founded
  • EDSA 2015
  • AMIX 2014
  • Country
  • EDSA Canada
  • AMIX United States
  • Employees
  • EDSA N/A
  • AMIX N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • AMIX
  • Sector
  • EDSA Health Care
  • AMIX
  • Exchange
  • EDSA Nasdaq
  • AMIX NYSE
  • Market Cap
  • EDSA 6.2M
  • AMIX 5.5M
  • IPO Year
  • EDSA N/A
  • AMIX N/A
  • Fundamental
  • Price
  • EDSA $2.36
  • AMIX $2.08
  • Analyst Decision
  • EDSA Strong Buy
  • AMIX
  • Analyst Count
  • EDSA 1
  • AMIX 0
  • Target Price
  • EDSA $21.00
  • AMIX N/A
  • AVG Volume (30 Days)
  • EDSA 8.9K
  • AMIX 13.6K
  • Earning Date
  • EDSA 05-09-2025
  • AMIX 05-30-2025
  • Dividend Yield
  • EDSA N/A
  • AMIX N/A
  • EPS Growth
  • EDSA N/A
  • AMIX N/A
  • EPS
  • EDSA N/A
  • AMIX N/A
  • Revenue
  • EDSA N/A
  • AMIX N/A
  • Revenue This Year
  • EDSA N/A
  • AMIX N/A
  • Revenue Next Year
  • EDSA N/A
  • AMIX N/A
  • P/E Ratio
  • EDSA N/A
  • AMIX N/A
  • Revenue Growth
  • EDSA N/A
  • AMIX N/A
  • 52 Week Low
  • EDSA $1.55
  • AMIX $1.52
  • 52 Week High
  • EDSA $5.59
  • AMIX $75.80
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 51.83
  • AMIX 58.05
  • Support Level
  • EDSA $2.29
  • AMIX $1.61
  • Resistance Level
  • EDSA $2.40
  • AMIX $2.06
  • Average True Range (ATR)
  • EDSA 0.12
  • AMIX 0.12
  • MACD
  • EDSA 0.00
  • AMIX 0.08
  • Stochastic Oscillator
  • EDSA 87.88
  • AMIX 93.18

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Share on Social Networks: